Dupilumab every 2 weeks versus placebo in bilateral nasal polyposis on background intranasal corticosteroids

Phase 3, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Dupilumab + mometasone furoate nasal spray with Placebo + mometasone furoate nasal spray (2 arms). Primary endpoints: Change from baseline in nasal congestion symptom severity score, Change from baseline in endoscopic nasal polyp score and 1 more. Started Sep 2016; status: completed.